Logo image of PPCB

PROPANC BIOPHARMA INC (PPCB) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PPCB - US74346N7012 - Common Stock

0.2779 USD
-0.11 (-28.74%)
Last: 1/29/2026, 6:42:04 PM
0.255 USD
-0.02 (-8.24%)
After Hours: 1/29/2026, 6:42:04 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to PPCB. PPCB was compared to 525 industry peers in the Biotechnology industry. PPCB may be in some trouble as it scores bad on both profitability and health. PPCB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year PPCB has reported negative net income.
  • PPCB had a negative operating cash flow in the past year.
  • In the past 5 years PPCB always reported negative net income.
  • In the past 5 years PPCB always reported negative operating cash flow.
PPCB Yearly Net Income VS EBIT VS OCF VS FCFPPCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

  • With a Return On Assets value of -2147.26%, PPCB is not doing good in the industry: 95.81% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2147.26%
ROE N/A
ROIC N/A
ROA(3y)-3739.99%
ROA(5y)-6299.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PPCB Yearly ROA, ROE, ROICPPCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PPCB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PPCB Yearly Profit, Operating, Gross MarginsPPCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

0

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, PPCB has more shares outstanding
  • PPCB has a worse debt/assets ratio than last year.
PPCB Yearly Shares OutstandingPPCB Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50K 100K 150K 200K 250K
PPCB Yearly Total Debt VS Total AssetsPPCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500K 1M 1.5M

2.2 Solvency

  • PPCB has an Altman-Z score of -1315.83. This is a bad value and indicates that PPCB is not financially healthy and even has some risk of bankruptcy.
  • PPCB's Altman-Z score of -1315.83 is on the low side compared to the rest of the industry. PPCB is outperformed by 95.24% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1315.83
ROIC/WACCN/A
WACCN/A
PPCB Yearly LT Debt VS Equity VS FCFPPCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 -1M -2M -3M

2.3 Liquidity

  • A Current Ratio of 0.00 indicates that PPCB may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.00, PPCB is doing worse than 95.81% of the companies in the same industry.
  • A Quick Ratio of 0.00 indicates that PPCB may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.00, PPCB is not doing good in the industry: 95.81% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
PPCB Yearly Current Assets VS Current LiabilitesPPCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 98.43% over the past year.
EPS 1Y (TTM)98.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

  • PPCB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PPCB Price Earnings VS Forward Price EarningsPPCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PPCB Per share dataPPCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -200 -400 -600

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • PPCB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PROPANC BIOPHARMA INC / PPCB FAQ

Can you provide the ChartMill fundamental rating for PROPANC BIOPHARMA INC?

ChartMill assigns a fundamental rating of 0 / 10 to PPCB.


What is the valuation status of PROPANC BIOPHARMA INC (PPCB) stock?

ChartMill assigns a valuation rating of 0 / 10 to PROPANC BIOPHARMA INC (PPCB). This can be considered as Overvalued.


How profitable is PROPANC BIOPHARMA INC (PPCB) stock?

PROPANC BIOPHARMA INC (PPCB) has a profitability rating of 0 / 10.


Can you provide the financial health for PPCB stock?

The financial health rating of PROPANC BIOPHARMA INC (PPCB) is 0 / 10.